The AS01E adjuvant enhances the immunogenicity of the M72 antigens, leading to increased activation of the CD8+ T cells and the production of cytokines such as IFN-γ, both essential immune system components for protection against TB [54,55]. The gene discussed is CD8A; the disease is tuberculosis.